SpyGlass Pharma buys Santen unit Advanced Vision Science for about $13 million cash

Bitget2026/10/01 12:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SpyGlass Pharma bought Advanced Vision Science from Santen for about USD 13 million in cash, taking 100% of the shares.
The deal secures commercial-scale manufacturing capacity for intraocular lenses used in the Phase 3 BIM-IOL System trials.
AVS will remain the exclusive supplier of several IOL types to Santen for commercialization in Japan.
Ongoing licensing includes AVS’s hydrophobic acrylic lens material for Bausch + Lomb’s enVista IOL line.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyglass Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610010800PRIMZONEFULLFEED9837595) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SpyGlass Pharma buys Santen unit Advanced Vision Science for about $13 million cash

You may also like

Crypto prices